HomeREGULATORY
REGULATORY

Tailwind for Prevenar 13? Vaccine Panel Members Up for Its Use in High-Risk Elderly
(Sep.11.2018)

NIID Director General Takaji Wakita
Pfizer’s pneumococcal vaccine Prevenar 13 might not make it into the Japanese public immunization program for the entire elderly population, but it could for a certain high-risk subset, with its national health reimbursement for these people also in the cards ...
(LOG IN FOR FULL STORY)

News Calendar